PD-L1 inhibitors (anti-PD-L1 therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-L1 inhibitors (anti-PD-L1 therapy), covering 2017-07-24 to 2017-07-24. Get the full timeline:
Most recent: Clinical Trial Update: The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients